NEWS NAVIGATOR
Englemed logo
SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
ENGLEMED
Contact Englemed
Send an e-mail with your comments!
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
TODAY'S NEWS
Antiseptic on umbilical cord fights infection
Wed February 8th - Cleaning a newborn's umbilical cord at birth can help to limit infections, experts say today. More
Age - a risk factor for breast cancer death
Wed February 8th - Older women with breast cancer face a greater risk of succumbing to the disease than younger women, according to a Dutch study published today. More
THIS WEEK'S STORIES
Solid food weaning 'best'
Tues February 7th - Parents may do better for their infants by weaning them with solid food rather than with pureed food, British researchers report today. More
House-moves "bad" for children?
Tues February 7th - Children who move home frequently in childhood face an increased risk of poor health in later life, researchers warned today. More
Consuming fish during pregnancy 'improves' baby brain power
Mon February 6th - Eating fish during pregnancy could bolster the infant’s intelligence, according to early findings from a major European study. More
Stroke gene found
Mon February 6th - British scientists have found a new gene linked to a common cause of stroke, it was announced last night. More
Malaria kills double the numbers originally believed
Mon February 6th - Malaria kills 1.2 million people a year – twice as many as previously thought – with almost half of the deaths being children over the age of five. More
ENGLEMED HEALTH NEWS

Hope for brain disease treatment

Monday November 16th, 2009

A drug used to treat Alzheimer's disease may be able to tackle another unpleasant brain disease, researchers reported last night.

Laboratory studies suggest that the drug Memantine may help against Huntington's disease - an inherited brain disease, scientists said.

The findings hinge on the idea that busy brains can stave off diseases such as Alzheimer's. The scientists at the Burnham Institute, La Jolla, California, USA, say they have shown how this works - because normal electrical signals in the brain, caused by mental activity, can stop disease.

The drug Memantine has a similar ability to keep brain activity normal, they say.

Reporting in Nature Medicine, the researchers say they have successfully treated laboratory mice bred to have human Huntington's disease. Human tests have also proved positive.

Researcher Professor Stuart Lipton said: "This verifies that appropriate electrical activity is protective, supporting the 'use it or lose it theory' of brain activity at the molecular level.

"For example, this finding may explain why epidemiologists have found that using your brain by performing crossword puzzles and other games can stave off cognitive decline in diseases like Alzheimer's."

He added: "By serendipity Memantine at the right concentration has the ability to protect the brain, probably not just from Alzheimer's but other diseases, in this case Huntington's."

The Californian researchers worked with a team at the University of British Columbia, Canada, on the project and are now hoping for a major international trial of the treatment.

Nature Medicine November 15 2009 doi:10.1038/nm.2056

Tags: Brain & Neurology | North America | Pharmaceuticals

Printer friendly page Printer friendly page

CATEGORIES